loadpatents
name:-0.10359001159668
name:-0.11132216453552
name:-0.01654314994812
DiMarchi; Richard D. Patent Filings

DiMarchi; Richard D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DiMarchi; Richard D..The latest application filed is for "fgf21 c-terminal peptide optimization".

Company Profile
19.125.103
  • DiMarchi; Richard D. - Carmel IN
  • DiMarchi; Richard D. - Bloomington IN US
  • - Carmel IN US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
FGF21 C-terminal peptide optimization
Grant 11,351,268 - DiMarchi , et al. June 7, 2
2022-06-07
Fgf21 C-terminal Peptide Optimization
App 20200360530 - DiMARCHI; Richard D. ;   et al.
2020-11-19
Glucagon/GLP-1 receptor co-agonists
Grant 10,730,923 - DiMarchi , et al.
2020-08-04
Insulin-incretin conjugates
Grant 10,696,726 - DiMarchi , et al. June 30, 2
2020-06-30
Aqueously soluble and chemically stable glucagon peptides
Grant 10,683,334 - Dimarchi , et al.
2020-06-16
Glucagon-t3 Conjugates
App 20190388510 - DIMARCHI; Richard D. ;   et al.
2019-12-26
Glucagon-like Peptide-1-t3 Conjugates
App 20190290772 - DIMARCHI; Richard D. ;   et al.
2019-09-26
Lipidated amide-based insulin prodrugs
Grant 10,385,107 - Dimarchi , et al. A
2019-08-20
Aqueously Soluble & Chemically Stable Glucagon Peptides
App 20190218268 - DIMARCHI; Richard D. ;   et al.
2019-07-18
Fgf21 C-terminal Peptide Optimization
App 20190142963 - DIMARCHI; Richard D. ;   et al.
2019-05-16
Glucagon/glp-1 Receptor Co-agonists
App 20190127433 - DiMARCHI; Richard D. ;   et al.
2019-05-02
Incretin-insulin conjugates
Grant 10,232,020 - Dimarchi , et al.
2019-03-19
Single chain insulin agonists exhibiting high activity at the insulin receptor
Grant 10,233,225 - DiMarchi , et al.
2019-03-19
Glucagon/GLP-1 receptor co-agonists
Grant 10,174,093 - DiMarchi , et al. J
2019-01-08
Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptides
Grant 10,137,170 - Belli , et al. November 27, 2
2018-11-27
Insulin-incretin Conjugates
App 20180194827 - DiMARCHI; Richard D. ;   et al.
2018-07-12
Analogs Of Glucagon Exhibiting Gip Receptor Activity
App 20180105569 - DiMARCHI; Richard D. ;   et al.
2018-04-19
Analogs of glucagon exhibiting GIP receptor activity
Grant 9,868,772 - Dimarchi , et al. January 16, 2
2018-01-16
Glucagon/glp-1 Receptor Co-agonists
App 20170349642 - DiMARCHI; Richard D. ;   et al.
2017-12-07
Insulin Receptor Partial Agonists
App 20170313755 - DiMARCHI; Richard D. ;   et al.
2017-11-02
GIP receptor-active glucagon compounds
Grant 9,790,263 - DiMarchi , et al. October 17, 2
2017-10-17
Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
Grant 9,783,592 - DiMarchi , et al. October 10, 2
2017-10-10
Lipidated Amide-based Insulin Prodrugs
App 20170283479 - DIMARCHI; Richard D. ;   et al.
2017-10-05
Incretin-insulin Conjugates
App 20170281788 - DIMARCHI; Richard D. ;   et al.
2017-10-05
Glucagon/GLP-1 receptor co-agonists
Grant 9,758,562 - DiMarchi , et al. September 12, 2
2017-09-12
O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
Grant 9,707,276 - Meehl , et al. July 18, 2
2017-07-18
Insulin analog dimers
Grant 9,593,156 - Dimarchi , et al. March 14, 2
2017-03-14
Glucagon analogs exhibiting GIP receptor activity
Grant 9,587,005 - DiMarchi , et al. March 7, 2
2017-03-07
CTP-based insulin analogs for treatment of diabetes
Grant 9,573,987 - Dimarchi , et al. February 21, 2
2017-02-21
Single Chain Insulin Agonists Exhibiting High Activity At The Insulin Receptor
App 20160340400 - DiMARCHI; Richard D. ;   et al.
2016-11-24
Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
Grant 9,487,571 - DiMarchi , et al. November 8, 2
2016-11-08
Lipidated Incretin Receptor Ligand Human Immunoglobulin Fc-region Fusion Polypeptides
App 20160310575 - BELLI; Sara ;   et al.
2016-10-27
Single-chain insulin agonists exhibiting high activity at the insulin receptor
Grant 9,458,220 - DiMarchi , et al. October 4, 2
2016-10-04
Glucagon/GLP-1 receptor co-agonists
Grant 9,447,162 - Day , et al. September 20, 2
2016-09-20
Methods For Treating Metabolic Disorders And Obesity With Gip And Glp-1 Receptor-active Glucagon-based Peptides
App 20160175400 - Vignati; Louis ;   et al.
2016-06-23
Dipeptide Linked Medicinal Agents
App 20160158375 - DiMARCHI; Richard D.
2016-06-09
Glucagon analogs exhibiting GIP receptor activity
Grant 9,340,600 - DiMarchi May 17, 2
2016-05-17
Glucagon Analogs Exhibiting GIP Receptor Activity
App 20160115215 - Dimarchi; Richard D. ;   et al.
2016-04-28
Glucagon/GLP-1 receptor co-agonists
Grant 9,309,301 - Dimarchi , et al. April 12, 2
2016-04-12
Prodrugs With Prolonged Action
App 20160058881 - DIMARCHI; RICHARD D. ;   et al.
2016-03-03
Glucagon Superfamily Peptides Exhibiting G Protein-coupled Receptor Activity
App 20160051688 - DiMARCHI; Richard D. ;   et al.
2016-02-25
Gip Receptor-active Glucagon Compounds
App 20160052989 - DiMARCHI; Richard D. ;   et al.
2016-02-25
Modified human four helical bundle polypeptides and their uses
Grant 9,260,472 - Cho , et al. February 16, 2
2016-02-16
Glucagon analogs exhibiting GIP receptor activity
Grant 9,249,206 - DiMarchi , et al. February 2, 2
2016-02-02
Insulin-incretin Conjugates
App 20160024169 - DIMARCHI; RICHARD D. ;   et al.
2016-01-28
O-glycosylated Carboxy Terminal Portion (ctp) Peptide-based Insulin And Insulin Analogues
App 20150374795 - DiMarchi; Richard D. ;   et al.
2015-12-31
Glucagon/glp-1 Receptor Co-agonists
App 20150376256 - DiMARCHI; Richard D. ;   et al.
2015-12-31
Analogs Of Glucagon Exhibiting Gip Receptor Activity
App 20150368310 - Dimarchi; Richard D. ;   et al.
2015-12-24
Gip-based Mixed Agonists For Treatment Of Metabolic Disorders And Obesity
App 20150322130 - DiMARCHI; Richard D. ;   et al.
2015-11-12
Glucagon Superfamily Peptides Exhibiting Nuclear Hormone Receptor Activity
App 20150320871 - DiMARCHI; Richard D. ;   et al.
2015-11-12
Ctp-based Insulin Analogs For Treatment Of Diabetes
App 20150299285 - DIMARCHI; Richard D. ;   et al.
2015-10-22
Glucagon/GLP-1 receptor co-agonists
Grant 9,156,902 - DiMarchi , et al. October 13, 2
2015-10-13
GIP receptor-active glucagon compounds
Grant 9,150,632 - Dimarchi , et al. October 6, 2
2015-10-06
Insulin Analog Dimers
App 20150274802 - Dimarchi; Richard D. ;   et al.
2015-10-01
Glucagon superfamily peptides exhbiting G protein coupled receptor activity
Grant 9,145,451 - DiMarchi , et al. September 29, 2
2015-09-29
Glucagon Analogs Exhibiting GIP Receptor Activity
App 20150259393 - DiMARCHI; Richard D. ;   et al.
2015-09-17
Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
Grant 9,127,088 - DiMarchi , et al. September 8, 2
2015-09-08
Ester-based insulin prodrugs
Grant 9,089,539 - DiMarchi , et al. July 28, 2
2015-07-28
Modified human plasma polypeptide or Fc scaffolds and their uses
Grant 9,074,010 - Sheffer , et al. July 7, 2
2015-07-07
GIP-based mixed agonists for treatment of metabolic disorders and obesity
Grant 9,062,124 - Dimarchi , et al. June 23, 2
2015-06-23
Single-chain Insulin Agonists Exhibiting High Activity At The Insulin Receptor
App 20150148520 - DiMARCHI; Richard D. ;   et al.
2015-05-28
Glucagon/glp-1 Receptor Co-agonists
App 20150126440 - DAY; Jonathan ;   et al.
2015-05-07
Glucagon analogs exhibiting physiological solubility and stability
Grant 9,018,164 - DiMarchi , et al. April 28, 2
2015-04-28
Glucagon antagonists
Grant 8,981,047 - Dimarchi , et al. March 17, 2
2015-03-17
Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activity
Grant 8,980,830 - Dimarchi , et al. March 17, 2
2015-03-17
Methods for treating metabolic disorders and obesity with a peptide comprising the amino acid sequence of SEQ ID No. 146
Grant 8,975,223 - Vignati , et al. March 10, 2
2015-03-10
Amide based glucagon and superfamily peptide prodrugs
Grant 8,969,288 - DiMarchi , et al. March 3, 2
2015-03-03
Amide-based insulin prodrugs
Grant 8,946,147 - DiMarchi , et al. February 3, 2
2015-02-03
Single-chain insulin agonists exhibiting high activity at the insulin receptor
Grant 8,940,860 - DiMarchi , et al. January 27, 2
2015-01-27
Modified human four helical bundle polypeptides and their uses
Grant 8,906,676 - Cho , et al. December 9, 2
2014-12-09
Modified human four helical bundle polypeptides and their uses
Grant 8,907,064 - Cho , et al. December 9, 2
2014-12-09
Glucagon/GLP-1 receptor co-agonists
Grant 8,900,593 - Day , et al. December 2, 2
2014-12-02
Glucagon superfamily peptides exhibiting glucocorticoid receptor activity
Grant 8,859,491 - DiMarchi , et al. October 14, 2
2014-10-14
Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
App 20140296487 - SHEFFER; Joseph ;   et al.
2014-10-02
Glucagon/glp-1 Receptor Co-agonists
App 20140221283 - Dimarchi; Richard D. ;   et al.
2014-08-07
Ester-based Insulin Prodrugs
App 20140212419 - DiMARCHI; Richard D. ;   et al.
2014-07-31
Glucagon/glp-1 Receptor Co-agonists
App 20140206607 - Dimarchi; Richard D. ;   et al.
2014-07-24
Human growth hormone modified at position 35
Grant 8,778,880 - Cho , et al. July 15, 2
2014-07-15
Amide based glucagon superfamily peptide prodrugs
Grant 8,778,872 - DiMarchi , et al. July 15, 2
2014-07-15
Glucagon/GLP-1 receptor co-agonists
Grant 8,729,017 - DiMarchi , et al. May 20, 2
2014-05-20
Glucagon/GLP-1 receptor co-agonists
Grant 8,703,701 - DiMarchi April 22, 2
2014-04-22
Glucagon Antagonist-gip Agonist Conjugates And Compositions For The Treatment Of Metabolic Disorders And Obesity
App 20140107021 - DiMARCHI; Richard D. ;   et al.
2014-04-17
Amide based insulin prodrugs
Grant 8,697,632 - DiMarchi , et al. April 15, 2
2014-04-15
Ester-based insulin prodrugs
Grant 8,697,838 - Dimarchi , et al. April 15, 2
2014-04-15
Glucagon analogs exhibiting enhanced solubility in physiological pH buffers
Grant 8,669,228 - Dimarchi , et al. March 11, 2
2014-03-11
Incretin Receptor Ligand Polypeptide Fc-Region Fusion Polypeptides And Conjugates With Altered Fc-Effector Function
App 20140051834 - HOFFMAN; Eike ;   et al.
2014-02-20
Stabilized glucagon solutions and uses therefor
Grant 8,636,711 - Ward , et al. January 28, 2
2014-01-28
Methods For Treating Metabolic Disorders And Obesity With Gip And Glp-1 Receptor-active Glucagon-based Peptides
App 20140018291 - Vignati; Louis ;   et al.
2014-01-16
Glucagon Analogs Exhibiting Gip Receptor Activity
App 20140011738 - DiMARCHI; Richard D.
2014-01-09
Modified human plasma polypeptide or Fc scaffolds and their uses
Grant 08618257 -
2013-12-31
Modified human plasma polypeptide or Fc scaffolds and their uses
Grant 8,618,257 - Sheffer , et al. December 31, 2
2013-12-31
Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
Grant 8,551,946 - Dimarchi , et al. October 8, 2
2013-10-08
Glucagon/GLP-1 receptor co-agonists
Grant 8,546,327 - Dimarchi , et al. October 1, 2
2013-10-01
Glucagon analogs exhibiting GIP receptor activity
Grant 8,507,428 - DiMarchi , et al. August 13, 2
2013-08-13
Glucagon/glp-1 Receptor Co-agonists
App 20130203660 - DAY; Jonathan ;   et al.
2013-08-08
Single-chain Insulin Agonists Exhibiting High Activity At The Insulin Receptor
App 20130203665 - DiMarchi; Richard D. ;   et al.
2013-08-08
Insulin analogs
Grant 8,481,485 - DiMarchi , et al. July 9, 2
2013-07-09
Glucagon Superfamily Peptides Exhibiting Glucocorticoid Receptor Activity
App 20130157934 - DiMARCHI; Richard D. ;   et al.
2013-06-20
Glucagon/GLP-1 receptor co-agonists
Grant 8,454,971 - Day , et al. June 4, 2
2013-06-04
Dipeptide Linked Medicinal Agents
App 20130137849 - DiMarchi; Richard D.
2013-05-30
Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers
Grant 8,450,270 - Dimarchi , et al. May 28, 2
2013-05-28
Amide Based Glucagon Superfamily Peptide Prodrugs
App 20130123462 - Dimarchi; Richard D. ;   et al.
2013-05-16
Amide-based Insulin Prodrugs
App 20130123171 - DiMarchi; Richard D. ;   et al.
2013-05-16
Glucagon Superfamily Peptides Exhibiting Nuclear Hormone Receptor Activity
App 20130123178 - DiMarchi; Richard D. ;   et al.
2013-05-16
Glucagon Superfamily Peptides Exhbiting G Protein Coupled Receptor Activity
App 20130116172 - Dimarchi; Richard D. ;   et al.
2013-05-09
Glucagon Analogs Exhibiting GIP Receptor Activity
App 20130116173 - DiMARCHI; Richard D. ;   et al.
2013-05-09
Glucagon/glp-1 Receptor Co-agonists
App 20120329708 - DiMARCHI; Richard D. ;   et al.
2012-12-27
Glucagon/glp-1 Receptor Co-agonists
App 20120329707 - DiMARCHI; Richard D. ;   et al.
2012-12-27
Glucagon analogs exhibiting physiological solubility and stability
Grant 8,338,368 - Dimarchi , et al. December 25, 2
2012-12-25
Glucagon Antagonist-gip Agonist Conjugates And Compositions For The Treatment Of Metabolic Disorders And Obesity
App 20120322725 - Dimarchi; Richard D. ;   et al.
2012-12-20
Glucagon/glp-1 Receptor Co-agonists
App 20120288511 - Dimarchi; Richard D.
2012-11-15
Glucagon Analogs Exhibiting Gip Receptor Activity
App 20120238493 - DiMARCHI; Richard D. ;   et al.
2012-09-20
Glucagon Analogs Exhibiting Physiological Solubility And Stability
App 20120196804 - DiMARCHI; Richard D. ;   et al.
2012-08-02
Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
App 20120190827 - SHEFFER; Joseph ;   et al.
2012-07-26
Gip Receptor-active Glucagon Compounds
App 20120172295 - Dimarchi; Richard D. ;   et al.
2012-07-05
Glucagon Antagonists
App 20120122783 - Dimarchi; Richard D. ;   et al.
2012-05-17
Modified human growth hormone
Grant 8,143,216 - Cho , et al. March 27, 2
2012-03-27
Stabilized Glucagon Solutions And Uses Therefor
App 20120071817 - Ward; W. Kenneth ;   et al.
2012-03-22
Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
App 20120041180 - SHEFFER; Joseph ;   et al.
2012-02-16
Modified Human Growth Hormone
App 20110294161 - CHO; Ho Sung ;   et al.
2011-12-01
Amide Based Glucagon And Superfamily Peptide Prodrugs
App 20110288003 - DiMarchi; Richard D. ;   et al.
2011-11-24
Modified human plasma polypeptide or Fc scaffolds and their uses
Grant 8,053,560 - Sheffer , et al. November 8, 2
2011-11-08
Insulin Analogs
App 20110257091 - DiMarchi; Richard D. ;   et al.
2011-10-20
Amide Based Insulin Prodrugs
App 20110257076 - DiMarchi; Richard D. ;   et al.
2011-10-20
Glucagon/glp-1 Receptor Co-agonists
App 20110257092 - Dimarchi; Richard D. ;   et al.
2011-10-20
Yl-based Insulin-like Growth Factors Exhibiting High Activity At The Insulin Receptor
App 20110245164 - DiMarchi; Richard D. ;   et al.
2011-10-06
Dipeptide Linked Medicinal Agents
App 20110237493 - DiMarchi; Richard D.
2011-09-29
Modified human plasma polypeptide or Fc scaffolds and their uses
Grant 8,022,186 - Sheffer , et al. September 20, 2
2011-09-20
Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
App 20110207914 - SHEFFER; Joseph ;   et al.
2011-08-25
GLUCAGON ANALOGS EXHIBITING ENHANCED SOLUBILITY AND STABILITY IN PHYSIOLOGICAL pH BUFFERS
App 20110190200 - DiMarchi; Richard D. ;   et al.
2011-08-04
Gip-based Mixed Agonists For Treatment Of Metabolic Disorders And Obesity
App 20110166062 - Dimarchi; Richard D. ;   et al.
2011-07-07
Modified human growth horomone polypeptides and their uses
Grant 7,939,496 - Cho , et al. May 10, 2
2011-05-10
Compounds Exhibiting Glucagon Antagonist And Glp-1 Agonist Activity
App 20110098217 - Dimarchi; Richard D. ;   et al.
2011-04-28
Modified human plasma polypeptide or Fc scaffolds and their uses
Grant 7,919,591 - Sheffer , et al. April 5, 2
2011-04-05
Ester-based Peptide Prodrugs
App 20110065633 - Dimarchi; Richard D. ;   et al.
2011-03-17
Glucagon/glp-1 Receptor Co-agonists
App 20100190701 - Day; Jonathan ;   et al.
2010-07-29
GLUCAGON ANALOGS EXHIBITING ENHANCED SOLUBILITY IN PHYSIOLOGICAL pH BUFFERS
App 20100190699 - Dimarchi; Richard D. ;   et al.
2010-07-29
Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
App 20100160212 - Sheffer; Joseph ;   et al.
2010-06-24
Glucagon Analogs Exhibiting Physiological Solubility And Stability
App 20090137456 - Dimarchi; Richard D. ;   et al.
2009-05-28
Modified Human Four Helical Bundle Polypeptides And Their Uses
App 20080300163 - Cho; Ho Sung ;   et al.
2008-12-04
Modified Human Four Helical Bundle Polypeptides and Their Uses
App 20080207877 - CHO; Ho Sung ;   et al.
2008-08-28
Modified Human Four Helical Bundle Polypeptides and Their Uses
App 20080161539 - CHO; Ho Sung ;   et al.
2008-07-03
Modified Human Four Helical Bundle Polypeptides and Their Uses
App 20080146781 - CHO; Ho Sung ;   et al.
2008-06-19
Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
App 20080125574 - SHEFFER; Joseph ;   et al.
2008-05-29
Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
App 20080113412 - SHEFFER; Joseph ;   et al.
2008-05-15
Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
App 20080113411 - SHEFFER; Joseph ;   et al.
2008-05-15
Modified Human Growth Hormone Polypeptides and Their Uses
App 20080108797 - CHO; Ho Sung ;   et al.
2008-05-08
Modified Human Growth Hormone
App 20080107680 - Cho; Ho Sung ;   et al.
2008-05-08
Modified Human Growth Hormone Polypeptides and Their Uses
App 20080103293 - CHO; Ho Sung ;   et al.
2008-05-01
Modified Human Growth Hormone Polypeptides and Their Uses
App 20080103294 - CHO; Ho Sung ;   et al.
2008-05-01
Modified Human Growth Hormone
App 20080102124 - CHO; Ho Sung ;   et al.
2008-05-01
Modified Human Growth Hormone
App 20080102125 - CHO; Ho Sung ;   et al.
2008-05-01
Modified Human Four Helical Bundle Polypeptides and Their Uses
App 20080097083 - CHO; Ho Sung ;   et al.
2008-04-24
Modified human growth hormone
App 20060189529 - Cho; Ho Sung ;   et al.
2006-08-24
Modified human growth hormone polypeptides and their uses
App 20050170404 - Cho, Ho Sung ;   et al.
2005-08-04
Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity
Grant 6,191,102 - DiMarchi , et al. February 20, 2
2001-02-20
Anti-obesity proteins
Grant 5,851,995 - Basinski , et al. December 22, 1
1998-12-22
Anti-obesity proteins
Grant 5,719,266 - DiMarchi , et al. February 17, 1
1998-02-17
Process for preparing insulin analogs
Grant 5,700,662 - Chance , et al. December 23, 1
1997-12-23
Anti-obesity proteins
Grant 5,691,309 - Basinski , et al. November 25, 1
1997-11-25
Anti-obesity proteins
Grant 5,605,886 - Basinski , et al. February 25, 1
1997-02-25
Anti-obesity proteins
Grant 5,594,104 - Basinski , et al. January 14, 1
1997-01-14
Anti-obesity proteins
Grant 5,580,954 - DiMarchi , et al. December 3, 1
1996-12-03
Anti-obesity proteins
Grant 5,569,743 - DiMarchi , et al. October 29, 1
1996-10-29
Anti-obesity proteins
Grant 5,569,744 - Basinski , et al. October 29, 1
1996-10-29
Anti-obesity proteins
Grant 5,567,678 - DiMarchi , et al. October 22, 1
1996-10-22
Anti-obesity proteins
Grant 5,563,245 - DiMarchi , et al. October 8, 1
1996-10-08
Anti-obesity proteins
Grant 5,563,243 - DiMarchi , et al. October 8, 1
1996-10-08
Anti-obesity proteins
Grant 5,563,244 - DiMarchi , et al. October 8, 1
1996-10-08
Anti-obesity proteins
Grant 5,559,208 - Basinski , et al. September 24, 1
1996-09-24
Anti-obesity proteins
Grant 5,554,727 - Basinski , et al. September 10, 1
1996-09-10
Anti-obesity proteins
Grant 5,552,524 - Basinski , et al. September 3, 1
1996-09-03
Anti-obesity proteins
Grant 5,552,522 - DiMarchi , et al. September 3, 1
1996-09-03
Anti-obesity proteins
Grant 5,532,336 - DiMarchi , et al. July 2, 1
1996-07-02
Anti-obesity proteins
Grant 5,525,705 - DiMarchi , et al. June 11, 1
1996-06-11
Anti-obesity proteins
Grant 5,521,283 - DiMarchi , et al. May 28, 1
1996-05-28
Insulin analogs modified at position 29 of the B chain
Grant 5,514,646 - Chance , et al. May 7, 1
1996-05-07
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
Grant 5,512,549 - Chen , et al. April 30, 1
1996-04-30
A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
Grant 5,304,473 - Belagaje , et al. April 19, 1
1994-04-19
Selective chemical removal of a protein amino-terminal residue
Grant 4,782,139 - DiMarchi , et al. November 1, 1
1988-11-01
Synthetic vaccines for foot and mouth disease
Grant 4,732,971 - DiMarchi , et al. March 22, 1
1988-03-22
Growth hormone release factor analogs
Grant 4,617,149 - DiMarchi , et al. October 14, 1
1986-10-14
Process for purifying proinsulin-like materials
Grant 4,616,078 - DiMarchi October 7, 1
1986-10-07
Process for inhibiting peptide carbamylation
Grant 4,605,513 - DiMarchi August 12, 1
1986-08-12
Company Registrations
SEC0001311733DiMarchi Richard D

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed